Bioreagents

BIOVECTRA offers a selection of high-quality Bioprocessing Reagents that are available in a variety of sizes from gram quantities for research and testing to multi-kg scale for manufacturing operations. Several of our Bioprocessing Reagents are available in cGMP grade, which provides our customers with an industry-leading level of quality and compliance to support their cGMP manufacturing operations.

BIOVECTRA also offers Diagnostic & Molecular Biology Reagents. These products are traditionally used as substrates for the detection of diagnostic enzymes or in molecular biology.

Display Logo Biovectra
ProductDescription / UseCAS #BIOVECTRA Catalogue #
DTTDithiothreitolIndustry-leading quality and reliability (Purity ≥ 99%)
Reagent used for maintaining thiol groups in a reduced state during protein processing, isolation, and denaturing
Incorporated into some leading COVID-19 testing kits
3483-12-31365
Dithiothreitol – Molecular Biology GradePremium MBG grade
Includes additional testing for: Protease, Rnase, Dnase, ICP metals
3483-12-31365 MBG
Dithiothreitol – cGMPPremium cGMP grade
Includes additional testing: Residual solvents
3483-12-31370
DTEDithioerythritolReagent used for maintaining thiol groups in a reduced state during protein processing, isolation, and denaturing
Purity ≥ 99%
6892-68-81360
DHAADehydroascorbic acid
– cGMP
Premium cGMP grade
Reagent used in the oxidation of proteins and prep of ADC’s
490-83-51310
TCEPTris (2-carboxyethyl) phosphine, hydrochloride – cGMPPremium cGMP grade
Reagent used in the reduction of disulfide bonds and during prep of ADC’s
51805-45-91301
IPTGIsopropyl-β-D-Thiogalactopyranoside,
Non-Animal Origin
Galactosidase activation reagent used in recombinant microbial fermentation processes
Made with non-animal derived materials
367-93-11900
EDAC1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide HCIWater soluble cross-linker used to conjugate proteins and peptides25952-53-81339
PEP-KPhosphoenolpyruvate, Monopotassium SaltA substrate for the detection of Carboxylase4265-07-02553
Phosphoenolpyruvate, Tricyclohexylammonium SaltSubstrate for the detection of Carboxylase35556-70-82555
p-Nitrophenylphosphate, Ditris SaltSubstrate for the detection of Alkaline Phosphatase68189-42-42372
BCIP-T5-Bromo-4-Chloro-3-Indolyl Phosphate, p-Toluidine SaltSubstrate for the detection of alkaline phosphatase, frequently in immunodiagnostic applications6578-06-91176
XTTBenzene Sulfonic Acid HydrateWidely used to measure cell proliferation in toxicity assays111072-31-22525
MTXMethotrexate, USPReagent used as a cell selection reagent in the production and maintenance of high producing mammalian cell lines59-05-21322
IPTGIsopropyl-β-D-Thiogalactopyranoside,
Non-Animal Origin
Galactosidase activation reagent used in recombinant microbial fermentation processes
Made with non-animal derived materials
367-93-11900
EDAC1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide HCIWater soluble cross-linker used to conjugate proteins and peptides25952-53-81339

Bioprocessing Reagents

Industry-leading quality and reliability (Purity ≥ 99%). Reagent used for maintaining thiol groups in a reduced state during protein processing, isolation, and denaturing. Incorporated into some leading COVID-19 testing kits

CAS #

3483-12-3

BioVectra Catalogue #

1365

Premium MBG grade. Includes additional testing for: Protease, Rnase, Dnase, ICP metals

CAS #

3483-12-3

BioVectra Catalogue #

1365 MBG

Premium cGMP grade. Includes additional testing: Residual solvents

CAS #

3483-12-3

BioVectra Catalogue #

1370

Reagent used for maintaining thiol groups in a reduced state during protein processing, isolation, and denaturing Purity ≥ 99%

CAS #

6892-68-8

BioVectra Catalogue #

1360

Premium cGMP grade. Reagent used in the oxidation of proteins and prep of ADC’s

CAS #

490-83-5

BioVectra Catalogue #

1310

Premium cGMP grade. Reagent used in the reduction of disulfide bonds and during prep of ADC’s

CAS #

51805-45-9

BioVectra Catalogue #

1301

Galactosidase activation reagent used in recombinant microbial fermentation processes. Made with non-animal derived materials

CAS #

367-93-1

BioVectra Catalogue #

1900

Water soluble cross-linker used to conjugate proteins and peptides

CAS #

25952-53-8

BioVectra Catalogue #

1339

Diagnostic & Molecular Biology Reagents

A substrate for the detection of Carboxylase

CAS #

4265-07-0

BioVectra Catalogue #

2553

Substrate for the detection of Carboxylase

CAS #

35556-70-8

BioVectra Catalogue #

2555

Substrate for the detection of Alkaline Phosphatase

CAS #

68189-42-4

BioVectra Catalogue #

2372

Substrate for the detection of alkaline phosphatase, frequently in immunodiagnostic applications

CAS #

6578-06-9

BioVectra Catalogue #

1176

Widely used to measure cell proliferation in toxicity assays

CAS #

111072-31-2

BioVectra Catalogue #

2525

Process Development

Demonstrated experience in process development and characterization, offering phase appropriate solutions and rapid optimization.

Analytical Development

Targeted analytical support from early development to validation of commercial processes and continuous process verification, all along the life cycle of your program.

Tech Transfer

Dedicated tech transfer teams ensuring a seamless transition from development to manufacturing - collaborating with our clients with a problem-solving mindset.

Clinical Development

Supplying our clients with pre-clinical and clinical material to enabling them to move quickly and cost-efficiently through the clinical phases.

Scale-Up

De-risking our client’s programs by effectively managing the transition from lab to pilot to manufacturing scale.

Commercial Scale

A proven history of commercial manufacturing partnerships growing alongside our clients. Effective collaboration increasing speed-to-market.

Browse Other Areas of Expertise

Synthetic Small Molecules

mRNA/pDNA

High Potency APIs

Project Support

Biologics

Ready to learn how BIOVECTRA can help? Contact us today!

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Normand Blais – Senior Director Development & Innovation, Biologics

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors